Mineralocorticoid receptor antagonism as an add-on treatment for resistant hypertension

被引:0
|
作者
Rossi, Gian Paolo [1 ]
Maiolino, Giuseppe [1 ]
机构
[1] Univ Padua, Dept Med DIMED, Padua, Italy
关键词
BLOOD-PRESSURE; SPIRONOLACTONE; PREVALENCE;
D O I
10.1038/hr.2014.139
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:1029 / 1031
页数:3
相关论文
共 50 条
  • [1] Mineralocorticoid receptor antagonism as an add-on treatment for resistant hypertension
    Gian Paolo Rossi
    Giuseppe Maiolino
    Hypertension Research, 2014, 37 : 1029 - 1031
  • [2] Consider mineralocorticoid receptor antagonists as add-on therapy in treatment-resistant hypertension
    Adis Medical Writers
    Drugs & Therapy Perspectives, 2015, 31 (10) : 345 - 349
  • [3] A Systematic Review of Add-on Pharmacologic Therapy in the Treatment of Resistant Hypertension
    Tataru, Anita P.
    Barry, Arden R.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (04) : 311 - 318
  • [4] A Systematic Review of Add-on Pharmacologic Therapy in the Treatment of Resistant Hypertension
    Anita P. Tataru
    Arden R. Barry
    American Journal of Cardiovascular Drugs, 2017, 17 : 311 - 318
  • [5] Usefulness of mineralocorticoid receptor antagonist for the treatment of resistant hypertension
    Kikkawa, Kohei
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 11P - 11P
  • [6] Results of the trycort: Cohort study of add-on antihypertensives for treatment of resistant hypertension
    Jankovic, Slobodan M.
    Stojkovic, Sinisa
    Petrovic, Milovan
    Kostic, Tomislav
    Zdravkovic, Marija
    Radovanovic, Slavica
    Cvjetan, Radosava
    Ratkovic, Nenad
    Rihor, Branislav
    Spiroski, Dejan
    Stankovic, Aleksandar
    Andelkovic, Branko
    Gocic Petrovic, Renata
    MEDICINE, 2023, 102 (22) : E33941
  • [7] Modulating the mineralocorticoid receptor as add-on therapy in antidepressant treatment with SSRI: a randomised controlled trial
    Otte, C.
    Hinkelmann, K.
    Moritz, S.
    Yassouridis, A.
    Jahn, H.
    Wiedemann, K.
    Kellner, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S193 - S194
  • [8] Effects of Add-on Therapy Consisting of a Selective Mineralocorticoid Receptor Blocker on Arterial Stiffness in Patients with Uncontrolled Hypertension
    Shibata, Takahiro
    Tsutsumi, Joshi
    Hasegawa, Jun
    Sato, Nobutaka
    Murashima, Eitatsu
    Mori, Chikara
    Hongo, Kenichi
    Yoshimura, Michihiro
    INTERNAL MEDICINE, 2015, 54 (13) : 1583 - 1589
  • [9] Mineralocorticoid Receptor Antagonism Improves Experimental Pulmonary Hypertension
    Preston, I. R.
    Sagliani, K. D.
    Warburton, R.
    Hill, N. S.
    Fanburg, B. L.
    Jaffe, I. Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [10] Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension
    Preston, Ioana R.
    Sagliani, Kristen D.
    Warburton, Rod R.
    Hill, Nicholas S.
    Fanburg, Barry L.
    Jaffe, Iris Z.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2013, 304 (10) : L678 - L688